In insolvency, knowing the true value of a startup’s intellectual property is crucial—it often defines whether the business can be revived, sold, or lost entirely.
A dispute between two pharmaceutical manufacturers gave rise to an important ruling by the Supreme Court on key issues with respect to Israeli statute of limitation (C.A, 5474/18 Unipharm Ltd. v. Glaxo SmitkKline p.l.c (18.6.2024).
In a recent decision, the District Court of Tel Aviv – Yafo (“the Court”), upheld the decision of the Patent Office (“the Office”) to reject APPLE Inc.’s application for the trademark
The Association Internationale pour la Protection de la Propriété Intellectuelle (AIPPI), or the International Association for the Protection of Intellectual Property
In a precedential and comprehensive ruling, rendered on April 9th, 2024, the Tel-Aviv District Court Judge, Gershon Gontovnik, acknowledged the right of “HaKibbutz HaMeuchad Publishing House”
The Israeli Commissioner of Patents (“the Commissioner”): Artificial intelligence (AI) cannot be considered an “inventor” within the meaning of such term in the Israeli Patents Law, 1967 (“the Patents Law”); therefore, AI cannot own or transfer an invention.
